乐凯胶片股份有限公司 关于参加 2025 年河北辖区上市公司投资者网上集体 接待日暨 2025 年半年报业绩说明会的公告 证券代码：600135 证券简称：乐凯胶片 公告编号：2025-045 本次活动将采用网络远程方式举行，投资者可登录"全景路演"网站 (http://rs.p5w.net)，或关注微信公众号：全景财经，或下载全景路演 APP，参与 本次互动交流，活动时间为 2025 年 9 月 15 日(周一)15:00-17:00。 届时公司董事长王洪泽，总经理路建波、财务总监谷永军、董事会秘书张永 光、独立董事文新祥将在线就公司治理、发展战略、经营状况等投资者所关心的 问题，与投资者深入交流，欢迎广大投资者踊跃参与! 特此公告。 乐凯胶片股份有限公司董事会 2025 年 9 月 9 日 1 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 为进一步加强与投资者的互动交流，乐凯胶片股份有限公司(以下简称"公 司")将参加由河北上市公司协会与深圳市全景网络有限公司联合举办的"2025 年 度河北辖区上市公司投资者网上集体接待日暨 2025 年半年 ...

Company Performance - LeKai Film reported a significant decline in net profit, down 66.26% year-on-year, with a total revenue of 644 million yuan, a decrease of 15.97% compared to the previous year [1] - The second quarter showed a total revenue of 354 million yuan, down 14.16% year-on-year, and a net profit of -24.34 million yuan, a staggering decline of 99.93% [1] - The gross margin improved slightly to 13.43%, an increase of 3.06% year-on-year, while the net margin fell to -7.76%, a decrease of 90.37% [1] Financial Metrics - Total revenue for 2024 was 766 million yuan, while for 2025 it dropped to 644 million yuan, reflecting a 15.97% decline [1] - The company’s cash assets are reported to be healthy, with cash funds increasing by 41.44% to 814 million yuan [3] - The company’s debt levels decreased significantly, with interest-bearing liabilities down 64.65% to 39 million yuan [1][3] Industry Overview - The imaging materials market is experiencing a decline in overall market capacity, with a shift in demand towards diverse output methods [4] - The photovoltaic materials sector is facing intense competition and price reductions, with major products experiencing a "volume increase, price decrease" trend [4] - The lithium battery materials market is growing rapidly, with significant increases in global shipments of automotive power batteries and energy storage batteries [5]

Core Insights - The company reported a total operating revenue of 644 million yuan, ranking 39th among disclosed peers, which represents a decrease of 122 million yuan or 15.97% year-on-year [1] - The net profit attributable to shareholders was -52.94 million yuan, ranking 53rd among peers, a decline of 21.10 million yuan compared to the same period last year [1] - The net cash flow from operating activities was -103 million yuan, ranking 50th among peers, down by 71.90 million yuan year-on-year [1] Financial Ratios - The latest debt-to-asset ratio is 11.74%, ranking 4th among peers, a decrease of 0.64 percentage points from the previous quarter and a reduction of 4.00 percentage points year-on-year [3] - The latest gross profit margin is 13.43%, ranking 36th among peers, with a slight increase of 0.02 percentage points from the previous quarter and an increase of 0.40 percentage points year-on-year [3] - The latest return on equity (ROE) is -2.19%, ranking 53rd among peers, a decrease of 0.90 percentage points compared to the same period last year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share is -0.10 yuan, ranking 52nd among peers, a decrease of 0.04 yuan year-on-year [3] - The latest total asset turnover ratio is 0.20 times, ranking 47th among peers, a decline of 0.04 times or 15.61% year-on-year [3] - The latest inventory turnover ratio is 1.81 times, ranking 40th among peers, an increase of 0.16 times or 9.71% year-on-year [3] Shareholder Information - The number of shareholders is 26,300, with the top ten shareholders holding 270 million shares, accounting for 48.87% of the total share capital [3] - The largest shareholder is China Lucky Group Co., Ltd., holding 456 million shares [3]

Group 1 - The company, LeKai Film, announced on August 28 that its 31st meeting of the 9th Board of Directors was held on August 27, 2025, in the office building meeting room [1] - The meeting reviewed the proposal to amend the company's information disclosure management system [1]

Group 1 - The core viewpoint of the article is that 乐凯胶片 (Lukai Film) reported a significant decline in revenue and net profit for the first half of 2025 [1] - The company achieved an operating income of 644 million yuan, representing a year-on-year decrease of 15.97% [1] - The net profit attributable to shareholders of the listed company was -53 million yuan, with a net profit of -61 million yuan after deducting non-recurring gains and losses [1] - The basic earnings per share were reported at -0.0957 yuan [1]

证券代码：600135 证券简称：乐凯胶片 公告编号：2025-043 乐凯胶片股份有限公司 九届三十一次董事会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 乐凯胶片股份有限公司（以下简称"公司"） 第九届董事会第三十一次会议 通知于 2025 年 8 月 15 日以邮件和电话的方式发出，会议于 2025 年 8 月 27 日在 办公楼会议室现场召开，会议应到董事 9 人，实到董事 9 人。公司部分高级管理 人员列席了会议。会议的召开符合《公司法》和公司章程的相关规定。会议审议 并一致通过了以下议案： 一、关于修订公司信息披露管理制度的议案 根据《上市公司信息披露管理办法》《上市公司信息披露暂缓与豁免管理规 定》等规定，结合公司实际，对公司信息披露管理制度进行修订，具体内容详见 公司同日发布的《乐凯胶片股份有限公司信息披露管理办法》。 同意 9 票，反对 0 票，弃权 0 票，表决通过。 二、关于制定公司信息披露暂缓与豁免管理细则的议案 根据《上市公司信息披露管理办法》《上市公司信息披露暂缓与豁免管理规 定》等规定，结合公司实际，制定了 ...

[Section 1 Definitions](index=4&type=section&id=Section%201%20Definitions) [Definitions of Common Terms](index=4&type=section&id=Definitions%20of%20Common%20Terms) This chapter defines common terms used throughout the report, including company, controlling shareholder, actual controller, and subsidiaries, ensuring clear understanding of the report's content Definitions of Common Terms | Common Term | Meaning | | :--- | :--- | | Company, This Company, Lucky Film | Lucky Film Company Limited | | Controlling Shareholder, Lucky Group, China Lucky | China Lucky Group Corporation | | Actual Controller, CASC | China Aerospace Science and Technology Corporation | | Lucky Medical | Lucky Medical Technology Co., Ltd. | | Lucky Optoelectronics | Lucky Optoelectronics Materials Co., Ltd. | | Reporting Period | January-June 2025 | | Shareholders' Meeting | Lucky Film Company Limited Shareholders' Meeting | | Board of Directors | Lucky Film Company Limited Board of Directors | | CSRC | China Securities Regulatory Commission | | Exchange, SSE | Shanghai Stock Exchange | | Yuan | Unless otherwise specified, refers to RMB Yuan | [Section 2 Company Profile and Key Financial Indicators](index=4&type=section&id=Section%202%20Company%20Profile%20and%20Key%20Financial%20Indicators) [I. Company Information](index=4&type=section&id=I.%20Company%20Information) This section outlines Lucky Film Company Limited's basic information, including its Chinese name, abbreviation, English name and abbreviation, and legal representative Company Basic Information | Indicator | Content | | :--- | :--- | | Chinese Name | 乐凯胶片股份有限公司 | | Chinese Abbreviation | 乐凯胶片 | | English Name | Lucky Film Company Limited | | English Name Abbreviation | Lucky Film Co.,Ltd. | | Legal Representative | Wang Hongze | [II. Contact Person and Information](index=4&type=section&id=II.%20Contact%20Person%20and%20Information) This section provides contact information for the company's Board Secretary and Securities Affairs Representative, including names, addresses, phone numbers, faxes, and email addresses, facilitating communication with investors and relevant parties Contact Information | Position | Name | Contact Address | Phone | Fax | Email | | :--- | :--- | :--- | :--- | :--- | :--- | | Board Secretary | Zhang Yongguang | No. 6 Lucky South Street, Baoding City, Hebei Province | 0312-7922692 | 0312-7922691 | stock@luckyfilm.com | | Securities Affairs Representative | Zhang Jun | No. 6 Lucky South Street, Baoding City, Hebei Province | 0312-7922692 | 0312-7922691 | stock@luckyfilm.com | [III. Brief Introduction to Changes in Basic Information](index=4&type=section&id=III.%20Brief%20Introduction%20to%20Changes%20in%20Basic%20Information) This section details the historical changes in the company's registered address and confirms no changes to the registered address, office address, website, or email during the reporting period - The company's registered address changed from No. 369 Chuangye Road, Baoding City, Hebei Province to No. 6 Jianye Road, Mancheng Economic Development Zone, Mancheng District, Baoding City, Hebei Province on **March 30, 2020**[16](index=16&type=chunk) - During the reporting period, there were no changes to the company's office address, website, or email address[16](index=16&type=chunk) [IV. Brief Introduction to Changes in Information Disclosure and Document Custody Locations](index=5&type=section&id=IV.%20Brief%20Introduction%20to%20Changes%20in%20Information%20Disclosure%20and%20Document%20Custody%20Locations) This section discloses the company's chosen information disclosure newspaper, the website address for the semi-annual report, and the location where the semi-annual report is kept, confirming no changes during the reporting period - The company's chosen information disclosure newspaper is Securities Daily, and the semi-annual report is published on the Shanghai Stock Exchange website (http://www.sse.com.cn)[17](index=17&type=chunk) - The company's semi-annual report is kept at the company's Board of Directors Office, with no changes during the reporting period[17](index=17&type=chunk) [V. Company Stock Overview](index=5&type=section&id=V.%20Company%20Stock%20Overview) This section provides basic information about the company's stock, including stock type, listing exchange, stock abbreviation, and stock code Company Stock Information | Stock Type | Listing Exchange | Stock Abbreviation | Stock Code | | :--- | :--- | :--- | :--- | | A-share | Shanghai Stock Exchange | 乐凯胶片 | 600135 | [VII. Key Accounting Data and Financial Indicators](index=5&type=section&id=VII.%20Key%20Accounting%20Data%20and%20Financial%20Indicators) During the reporting period, the company's operating revenue decreased by **15.97%** year-on-year, with total profit, net profit attributable to listed company shareholders, and net profit after deducting non-recurring gains and losses all showing expanded losses, primarily due to declining sales volumes and reduced selling prices of some key products Key Accounting Data (Jan-Jun 2025 vs. Prior Year Period) | Indicator | Current Period (Jan-Jun) | Prior Year Period | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 643,586,281.25 Yuan | 765,871,458.71 Yuan | -15.97 | | Total Profit | -48,074,811.35 Yuan | -27,743,402.61 Yuan | N/A | | Net Profit Attributable to Listed Company Shareholders | -52,939,432.17 Yuan | -31,840,498.70 Yuan | N/A | | Net Profit Attributable to Listed Company Shareholders After Deducting Non-Recurring Gains and Losses | -60,791,709.03 Yuan | -42,717,717.08 Yuan | N/A | | Net Cash Flow from Operating Activities | -102,762,749.76 Yuan | -30,867,197.29 Yuan | N/A | | Net Assets Attributable to Listed Company Shareholders (Period-end vs. Prior Year-end) | 2,418,336,123.60 Yuan | 2,469,423,818.55 Yuan | -2.07 | | Total Assets (Period-end vs. Prior Year-end) | 3,232,103,349.88 Yuan | 3,276,366,326.10 Yuan | -1.35 | Key Financial Indicators (Jan-Jun 2025 vs. Prior Year Period) | Indicator | Current Period (Jan-Jun) | Prior Year Period | YoY Change | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (Yuan/share) | -0.0957 | -0.0575 | N/A | | Diluted Earnings Per Share (Yuan/share) | -0.0957 | -0.0575 | N/A | | Basic Earnings Per Share After Deducting Non-Recurring Gains and Losses (Yuan/share) | -0.1099 | -0.0772 | N/A | | Weighted Average Return on Net Assets (%) | -2.1670 | -1.2847 | Decrease 0.8823 percentage points | | Weighted Average Return on Net Assets After Deducting Non-Recurring Gains and Losses (%) | -2.4885 | -1.7236 | Decrease 0.7649 percentage points | - Net profit attributable to listed company shareholders and net profit after deducting non-recurring gains and losses decreased year-on-year, primarily due to declining sales volumes and reduced selling prices of some key products, leading to a decrease in operating revenue[20](index=20&type=chunk) [IX. Non-Recurring Gains and Losses Items and Amounts](index=6&type=section&id=IX.%20Non-Recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) This section details non-recurring gains and losses items and their amounts for the reporting period, totaling **7,852,276.86 Yuan**, primarily including government grants and fair value changes in financial assets Non-Recurring Gains and Losses Items and Amounts | Non-Recurring Gains and Losses Item | Amount (Yuan) | | :--- | :--- | | Disposal gains and losses of non-current assets | -204,175.45 | | Government grants recognized in current profit or loss | 4,010,070.41 | | Gains and losses from changes in fair value of financial assets and liabilities held by non-financial enterprises and disposal gains and losses | 3,674,979.98 | | Other non-operating income and expenses | 84,147.94 | | Other gains and losses that meet the definition of non-recurring gains and losses | 1,342,768.52 | | Less: Income tax impact | 522,139.23 | | Minority interest impact (after tax) | 533,375.31 | | **Total** | **7,852,276.86** | [Section 3 Management Discussion and Analysis](index=7&type=section&id=Section%203%20Management%20Discussion%20and%20Analysis) [I. Explanation of the Company's Industry and Main Business Operations During the Reporting Period](index=7&type=section&id=I.%20Explanation%20of%20the%20Company's%20Industry%20and%20Main%20Business%20Operations%20During%20the%20Reporting%20Period) During the reporting period, the company focused on six major business segments—medical, imaging, photovoltaic, new energy, separation membranes, and cast optical films—in line with its '14th Five-Year Plan' strategic planning, building a comprehensive functional materials product system through technological innovation and product upgrades, with each industry segment experiencing varying development trends influenced by policies, market competition, and demand changes [(I) Main Business Operations](index=7&type=section&id=(I)%20Main%20Business%20Operations) The company, with 'high-quality development' as its core objective, strategically focuses on six major business segments: medical materials, imaging materials, photovoltaic materials, new energy materials, separation membrane materials, and cast optical film materials, having established a product matrix including medical dry films, industrial radiographic films, color photographic paper, lithium-ion battery separators, aluminum-plastic films, non-woven separation membranes, polyolefin separation membranes, and TAC films - The company, guided by its '14th Five-Year' strategic development plan, focuses on 'high-quality development' as its core objective, strategically laying out six major business segments: medical materials, imaging materials, photovoltaic materials, new energy materials, separation membrane materials, and cast optical film materials[23](index=23&type=chunk) - The company has established a comprehensive functional materials product system, with a product matrix including medical dry films, industrial radiographic films, color photographic paper, lithium-ion battery separators, aluminum-plastic films, non-woven separation membranes, polyolefin separation membranes, and TAC films[23](index=23&type=chunk) [(II) Industry Overview](index=7&type=section&id=(II)%20Industry%20Overview) Each business sector faced distinct challenges and opportunities during the reporting period: the medical imaging market is transitioning to digitalization due to policy impacts; the imaging market sees strong demand for online printing; the photovoltaic industry experienced significant new installations but intense price competition; the lithium battery market saw substantial growth in power and energy storage battery shipments; the cast optical film market was affected by trade policies, yet TAC film for polarized glasses grew; and the water treatment separation membrane market showed robust development with accelerating domestic substitution - Medical Materials: Influenced by national medical insurance policies, digital medical imaging is rapidly emerging, while the market capacity for physical medical imaging films has significantly declined[23](index=23&type=chunk) - Imaging Materials: Demand in the professional portrait market continues to decline, while the civilian imaging market sees strong demand, with online printing becoming a trend; the company will develop its own e-commerce platform and post-processing for imaging products[23](index=23&type=chunk) - Photovoltaic Materials: China's new photovoltaic installed capacity grew over **100%** year-on-year, but the industry incurred losses exceeding **18 billion Yuan**, with intense price competition in silicon material and wafer segments, while auxiliary materials performed steadily[24](index=24&type=chunk) - Lithium Battery Materials: In the first half, China's lithium battery shipments grew by **68%** year-on-year, with power batteries increasing by **49%**, energy storage batteries by **128%**, and 3C market consumption growing over **25%**[24](index=24&type=chunk) - Cast Optical Film Materials: Affected by international trade policies, demand for consumer products in the end market decreased, but TAC film for polarized glasses saw growth, with new production lines expected to drive sales growth in the second half of the year[24](index=24&type=chunk) - Separation Membrane Materials: The water treatment market is experiencing development opportunities, with separation membranes as a key technology, accelerating domestic substitution[25](index=25&type=chunk) [II. Discussion and Analysis of Operations](index=8&type=section&id=II.%20Discussion%20and%20Analysis%20of%20Operations) During the reporting period, the company's business segments actively responded to market changes: medical materials experienced profit fluctuations due to cloud imaging policies, prompting product structure optimization and new product promotion; imaging materials expanded market reach through online-offline integration; photovoltaic materials exited the domestic market to develop new products; lithium battery material sales grew over **50%** year-on-year, with aluminum-plastic film production and sales achieving significant growth; cast optical film material sales increased year-on-year, with new production lines targeting high-end markets; the 'High-Performance Separation Membrane and Components Project' for separation membrane materials commenced, showing good progress in industrial reverse osmosis membrane market development; and international business revenue achieved year-on-year growth - Medical Materials Business: Sales of medical dry films were stable but profits fluctuated significantly, impacted by the National Healthcare Security Administration's cloud imaging policy. The company will optimize its industrial layout and product structure, exploring new products and cloud imaging platforms[26](index=26&type=chunk) - Imaging Materials Business: Adopting an online-offline integrated strategy to consolidate market channels, stabilize color photographic paper sales, increase e-commerce development efforts, establish an imaging processing center, and expand new business growth points[26](index=26&type=chunk) - Photovoltaic Materials Business: Lucky Backsheet temporarily exited the domestic photovoltaic market while continuously developing new products based on market demand and production line adaptability[26](index=26&type=chunk) - Lithium Battery Materials Business: Steadfastly implementing a key account strategy and exploring emerging application scenarios, sales grew over **50%** year-on-year in the first half; aluminum-plastic film production and sales achieved leapfrog growth[26](index=26&type=chunk) - Cast Optical Film Materials Business: Comprehensively optimizing product structure and strengthening cost foundations, product sales achieved year-on-year growth in the first half; the new TAC film production line is seizing critical commissioning milestones, targeting the high-end optical film market[27](index=27&type=chunk) - Separation Membrane Materials Business: The 'High-Performance Separation Membrane and Components Project' officially commenced, with independently developed industrial reverse osmosis membranes maintaining a desalination rate of over **98%**, showing good market development results[27](index=27&type=chunk) - International Business: Leveraging specialized market promotion plans to precisely develop international markets, color photographic paper and industrial films achieved breakthroughs in European and other markets, resulting in year-on-year growth in international revenue[27](index=27&type=chunk) [III. Analysis of Core Competitiveness During the Reporting Period](index=8&type=section&id=III.%20Analysis%20of%20Core%20Competitiveness%20During%20the%20Reporting%20Period) The company's core competitiveness spans seven areas: brand, marketing, technological innovation, quality control, organizational management, human resources, and development platform; as an established film manufacturer, it boasts high recognition and reputation, a comprehensive marketing and service network, strong R&D capabilities with numerous core technologies and intellectual properties, a robust quality control system ensuring stable product performance, multiple management system certifications including international photovoltaic product certifications, a strong talent pool, and a listed state-owned enterprise background providing financial security and a favorable financing platform - Brand Advantage: As one of the world's three established film manufacturers, the company enjoys high recognition and reputation, with its national brand image and product quality acknowledged by customers[28](index=28&type=chunk) - Marketing Advantage: Possesses a comprehensive domestic marketing and service system, with extensive marketing network coverage, fast after-sales service, complete technical support, and highly qualified service personnel[28](index=28&type=chunk) - Technological Innovation Advantage: A national high-tech enterprise with an independent technology R&D center, mastering three core technologies—'coating, film formation, and microstructure'—and holding multiple independent intellectual property rights and science and technology progress awards[28](index=28&type=chunk) - Quality Control Advantage: Possesses a comprehensive quality and cost control system from raw materials to finished products, enhancing product quality and performance through independent R&D to maintain an advanced level[30](index=30&type=chunk) - Organizational Management Advantage: Certified with multiple management systems including ISO9001, ISO14001, ISO45001, ISO50001, and GB/T29490; photovoltaic products are UL (US) and TUV (Germany) certified, complying with EU environmental requirements[30](index=30&type=chunk) - Human Resources Advantage: Attracts professional technical talent, boasts a high-caliber research team, and has a comprehensive human resource system that maximizes employee motivation[30](index=30&type=chunk) - Development Platform Advantage: As a listed company, it leverages its platform for financing and development; its state-owned enterprise background provides a favorable financing platform, ensuring financial support for strategic planning[30](index=30&type=chunk) [IV. Key Operating Performance During the Reporting Period](index=9&type=section&id=IV.%20Key%20Operating%20Performance%20During%20the%20Reporting%20Period) During the reporting period, the company's operating revenue and costs both decreased, financial expenses increased, and net cash flow from operating activities significantly declined; the asset and liability structure changed, with a decrease in monetary funds and an increase in accounts receivable and right-of-use assets; net cash flow from investing activities decreased, primarily due to increased net wealth management investments; net cash flow from financing activities decreased, mainly due to equity acquisition payments in the prior year; major subsidiaries, particularly Lucky Medical and Lucky Optoelectronics, maintained good operating conditions with substantial total assets and net assets [(I) Main Business Analysis](index=9&type=section&id=(I)%20Main%20Business%20Analysis) During the reporting period, both operating revenue and operating costs decreased year-on-year, primarily due to intensified market competition in the photovoltaic industry and reduced sales volume and prices of backsheet products; financial expenses increased due to lower interest income, net cash flow from operating activities decreased due to lower sales revenue, net cash flow from investing activities decreased due to increased net wealth management investments, and net cash flow from financing activities decreased due to equity acquisition payments in the prior year Analysis Table of Financial Statement Item Changes (Jan-Jun 2025 vs. Prior Year Period) | Item | Current Period Amount (Yuan) | Prior Year Period Amount (Yuan) | Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 643,586,281.25 | 765,871,458.71 | -15.97 | | Operating Cost | 557,181,902.10 | 666,106,642.47 | -16.35 | | Selling Expenses | 25,242,072.23 | 29,097,770.79 | -13.25 | | Administrative Expenses | 61,256,691.40 | 66,901,510.13 | -8.44 | | Financial Expenses | -4,946,571.93 | -13,571,792.57 | N/A | | R&D Expenses | 50,289,155.09 | 50,605,143.45 | -0.62 | | Net Cash Flow from Operating Activities | -102,762,749.76 | -30,867,197.29 | N/A | | Net Cash Flow from Investing Activities | -359,714,560.72 | -323,594,471.09 | N/A | | Net Cash Flow from Financing Activities | -1,174,097.82 | -422,441,319.78 | N/A | - Primary reasons for changes in operating revenue and operating costs: intensified market competition in the photovoltaic industry, leading to reduced sales volume and prices of backsheet products[31](index=31&type=chunk) - Reason for change in financial expenses: decreased interest income in the current period led to increased financial expenses[31](index=31&type=chunk) - Reason for change in net cash flow from operating activities: decreased sales revenue in the current period resulted in reduced cash recovery from sales of goods and services[31](index=31&type=chunk) - Reason for change in net cash flow from investing activities: increased net wealth management investments in the current period[31](index=31&type=chunk) - Reason for change in net cash flow from financing activities: equity acquisition payments in the prior year resulted in higher cash outflows from financing activities compared to the current period[31](index=31&type=chunk) [(III) Analysis of Assets and Liabilities](index=10&type=section&id=(III)%20Analysis%20of%20Assets%20and%20Liabilities) At the end of the reporting period, the company's monetary funds decreased by **36.25%** due to idle funds being used for cash management, while accounts receivable increased by **127.87%** influenced by the collection patterns and cycles in the TAC film industry; right-of-use assets and lease liabilities significantly increased by **146.86%** and **958.07%** respectively, due to the renewal of existing production facility lease contracts Changes in Assets and Liabilities (Current Period End vs. Prior Year End) | Item Name | Current Period End Amount (Yuan) | Share of Total Assets (%) | Prior Year End Amount (Yuan) | Share of Total Assets (%) | YoY Change (%) | | :--- | :--- | :--- | :--- | :--- | :--- | | Monetary Funds | 813,807,951.11 | 25.18 | 1,276,593,973.33 | 38.96 | -36.25 | | Accounts Receivable | 215,169,078.72 | 6.66 | 94,424,962.84 | 2.88 | 127.87 | | Inventories | 306,828,583.16 | 9.49 | 308,295,659.22 | 9.41 | -0.48 | | Investment Properties | 8,925,535.21 | 0.28 | 9,060,711.55 | 0.28 | -1.49 | | Fixed Assets | 528,129,615.61 | 16.34 | 540,188,241.74 | 16.49 | -2.23 | | Construction in Progress | 319,003,177.93 | 9.87 | 268,157,465.27 | 8.18 | 18.96 | | Right-of-Use Assets | 32,020,218.13 | 0.99 | 12,970,761.12 | 0.40 | 146.86 | | Short-term Borrowings | 25,000,000.00 | 0.77 | 25,309,184.66 | 0.77 | -1.22 | | Contract Liabilities | 25,443,410.23 | 0.79 | 23,641,810.48 | 0.72 | 7.62 | | Lease Liabilities | 18,987,652.08 | 0.59 | 1,794,555.92 | 0.05 | 958.07 | - The decrease in monetary funds is primarily due to the company's idle funds being used for cash management, which had not matured by the end of the reporting period[33](index=33&type=chunk) - The increase in accounts receivable is mainly due to the collection patterns and cyclical nature of the TAC film industry, leading to an increase in accounts receivable for the company's TAC film segment[33](index=33&type=chunk) - The significant increase in right-of-use assets and lease liabilities is primarily due to the expiration of existing production facility lease contracts during the reporting period, with the company renewing lease agreements with lessors and re-recognizing them in accordance with relevant accounting standards[33](index=33&type=chunk) [(IV) Analysis of Investment Status](index=10&type=section&id=(IV)%20Analysis%20of%20Investment%20Status) This period, the company's ending balance of trading financial assets significantly increased to **421,629,274.55 Yuan**, a **236.55%** rise from the beginning of the period, primarily because current period purchases far exceeded sales/redemptions; other equity instrument investments and accounts receivable financing also changed Changes in Financial Assets Measured at Fair Value | Asset Category | Beginning Balance (Yuan) | Fair Value Change P/L (Yuan) | Current Period Purchases (Yuan) | Current Period Sales/Redemptions (Yuan) | Ending Balance (Yuan) | | :--- | :--- | :--- | :--- | :--- | :--- | | Trading Financial Assets | 125,282,875.58 | 1,666,398.97 | 621,180,000.00 | 326,500,000.00 | 421,629,274.55 | | Other Equity Instrument Investments | 212,562,596.67 | - | - | - | 212,562,596.67 | | Accounts Receivable Financing | 34,425,291.57 | - | 121,325,308.61 | 185,616,561.57 | 11,400,596.83 | | **Total** | **372,270,763.82** | **1,666,398.97** | **742,505,308.61** | **512,116,561.57** | **645,592,468.05** | [(VI) Analysis of Major Holding and Participating Companies](index=12&type=section&id=(VI)%20Analysis%20of%20Major%20Holding%20and%20Participating%20Companies) The company's major controlled subsidiaries include Lucky Medical, Shantou Lucky, Baoding Lucky Imaging, Baoding Lucky Import & Export, Beijing Lucky Sales, and Lucky Optoelectronics; among these, Lucky Medical and Lucky Optoelectronics have substantial total assets and net assets, with Lucky Medical reporting operating revenue of **208.88 million Yuan** and net profit of **3.08 million Yuan** for the period, and Lucky Optoelectronics reporting operating revenue of **116.35 million Yuan** and net profit of **6.04 million Yuan** Major Subsidiary Financial Information (Unit: 10,000 Yuan) | Company Name | Company Type | Main Business | Registered Capital | Total Assets | Net Assets | Operating Revenue | Operating Profit | Net Profit | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Lucky Medical Technology Co., Ltd. | Subsidiary | R&D, production, and sales of information chemicals, fine chemical products, medical devices, etc. | 12,988.05 | 53,286.61 | 39,650.69 | 20,888.27 | 382.12 | 307.95 | | Shantou Lucky Film Co., Ltd. | Subsidiary | R&D, production, and sales of color photographic paper | 8,000.00 | 17,265.90 | 12,707.43 | 9,751.27 | -93.79 | -96.09 | | Baoding Lucky Imaging Materials Technology Co., Ltd. | Subsidiary | R&D, production, and sales of processing chemicals for information imaging materials | 3,140.00 | 3,979.36 | 3,644.28 | 1,394.66 | 67.96 | 67.96 | | Baoding Lucky Import & Export Trading Co., Ltd. | Subsidiary | Self-operated and agency import and export business | 100.00 | 687.79 | 446.52 | 1,376.90 | 22.58 | 26.16 | | Beijing Lucky Film Sales Co., Ltd. | Subsidiary | Sales of photosensitive materials, photographic equipment, magnetic recording materials, etc. | 950.00 | 4,605.49 | 1,514.80 | 13,966.14 | 94.37 | 85.71 | | Lucky Optoelectronics Materials Co., Ltd. | Subsidiary | R&D, production, and sales of new film materials | 17,718.09 | 104,998.18 | 95,047.99 | 11,635.05 | 710.32 | 604.28 | [V. Other Disclosure Matters](index=12&type=section&id=V.%20Other%20Disclosure%20Matters) The company faces political, policy change, and industry risks; political risks primarily stem from international trade frictions and tariff adjustments, which the company addresses by closely monitoring the situation, adjusting strategies, and building strong government relations; policy change risks arise from medical insurance policies promoting cloud films, which the company counters by promoting 'cloud imaging' and intensifying international market development; industry risks mainly involve high silver prices, which the company manages by monitoring raw material markets, adjusting product structures, and sales strategies [(I) Potential Risks](index=12&type=section&id=(I)%20Potential%20Risks) The company faces political risks (international trade frictions, tariff adjustments), policy change risks (medical insurance policies promoting cloud films leading to demand decline), and industry risks (high silver prices); the company has formulated corresponding countermeasures, including closely monitoring the political situation, promoting 'cloud imaging', intensifying international market development, and flexibly adjusting procurement costs and product structure - Political Risks: The international political environment is becoming more complex, with escalating Sino-US trade frictions, EU anti-dumping investigations, and tariff adjustments potentially impacting raw material procurement, exports, and supply chains[37](index=37&type=chunk) - Countermeasures: Timely understanding of the political environment, close attention to changes in policies and regulations, formulation of response strategies, adjustment of company strategies, and establishment of good relationships with government and political stakeholders[39](index=39&type=chunk) - Policy Change Risks: The National Healthcare Security Administration's promotion of 'technical-consumable separation' and encouragement of 'cloud films' has led to a sharp decline in demand for medical dry films[39](index=39&type=chunk) - Countermeasures: Promoting Lucky 'Cloud Imaging', accelerating the sales model combining medical dry films with digital imaging services, and increasing independent development and export efforts in international markets[39](index=39&type=chunk) - Industry Risks: Sustained high prices of silver have led to a decline in product profitability[39](index=39&type=chunk) - Countermeasures: Closely monitoring raw material market supply, adopting flexible measures to reduce procurement costs, ensuring stable procurement, and adjusting product structure and sales strategies based on market demand[39](index=39&type=chunk) [Section 4 Corporate Governance, Environment, and Society](index=14&type=section&id=Section%204%20Corporate%20Governance,%20Environment,%20and%20Society) [I. Changes in Directors and Senior Management](index=14&type=section&id=I.%20Changes%20in%20Directors%20and%20Senior%20Management) During the reporting period, there were changes in the company's senior management, with Gu Yongjun appointed as Chief Financial Officer and Guan Chen resigning from the Chief Financial Officer position - Gu Yongjun was appointed as the company's Chief Financial Officer[42](index=42&type=chunk) - Guan Chen resigned from the position of Chief Financial Officer[42](index=42&type=chunk) [IV. Environmental Information of Listed Companies and Their Major Subsidiaries Included in the List of Enterprises Required to Disclose Environmental Information by Law](index=14&type=section&id=IV.%20Environmental%20Information%20of%20Listed%20Companies%20and%20Their%20Major%20Subsidiaries%20Included%20in%20the%20List%20of%20Enterprises%20Required%20to%20Disclose%20Environmental%20Information%20by%20Law) The company and its three major subsidiaries (Lucky Medical Technology Co., Ltd., Baoding Lucky Imaging Materials Technology Co., Ltd., and Shantou Lucky Film Co., Ltd.), totaling four entities, have been included in the list of enterprises required to disclose environmental information by law and have publicly disclosed their environmental information in the respective enterprise environmental information disclosure systems - A total of **4** of the company's entities were included in the list of enterprises required to disclose environmental information by law[43](index=43&type=chunk) - Lucky Film Company Limited, Lucky Medical Technology Co., Ltd., and Baoding Lucky Imaging Materials Technology Co., Ltd. disclosed environmental information in the Enterprise Environmental Information Disclosure System (Hebei)[43](index=43&type=chunk) - Shantou Lucky Film Co., Ltd. disclosed environmental information in the Guangdong Provincial Department of Ecology and Environment - Enterprise Environmental Information Disclosure System[43](index=43&type=chunk)[44](index=44&type=chunk) [Section 5 Significant Matters](index=16&type=section&id=Section%205%20Significant%20Matters) [I. Fulfillment of Commitments](index=16&type=section&id=I.%20Fulfillment%20of%20Commitments) During the reporting period, both the controlling shareholder, China Lucky Group Corporation, and the actual controller, China Aerospace Science and Technology Corporation, strictly fulfilled all commitments related to major asset restructuring and refinancing, including ensuring the company's independence, avoiding horizontal competition, regulating related party transactions, and patent and trademark usage, with all commitments strictly adhered to on schedule - Both the controlling shareholder, China Lucky Group Corporation, and the actual controller, China Aerospace Science and Technology Corporation, committed to ensuring Lucky Film's independence in personnel, assets, finance, organization, and business, and have strictly fulfilled these commitments[46](index=46&type=chunk) - All committing parties pledged to avoid horizontal competition with Lucky Film, refraining from engaging in businesses identical or similar to the company's, and have strictly fulfilled this commitment[47](index=47&type=chunk) - All committing parties pledged to minimize and regulate related party transactions with Lucky Film, conducting them at fair prices in accordance with market principles, and have strictly fulfilled this commitment[47](index=47&type=chunk) - China Lucky Group Corporation committed not to unilaterally use or implement patent rights jointly owned with Lucky Medical, and authorized Lucky Medical to use registered trademarks free of charge, which has been strictly fulfilled[47](index=47&type=chunk) - China Lucky Group Corporation committed to providing Lucky Medical with priority lease rights and the right to determine lease terms for leased land and properties, and to provide full cash compensation for any potential defects, which has been strictly fulfilled[47](index=47&type=chunk)[48](index=48&type=chunk) [X. Significant Related Party Transactions](index=19&type=section&id=X.%20Significant%20Related%20Party%20Transactions) The company engages in related party transactions such as purchasing and selling goods and providing labor in its daily operations, and conducts financial business with Aerospace Science and Technology Finance Co., Ltd. During the reporting period, the company's ending deposit balance with Aerospace Science and Technology Finance Co., Ltd. was **354.15 million Yuan**, with total deposits of **10.36 billion Yuan** and withdrawals of **10.87 billion Yuan** for the period; the company also obtained a **150 million Yuan** comprehensive credit facility from Aerospace Science and Technology Finance Co., Ltd [(I) Related Party Transactions Related to Daily Operations](index=19&type=section&id=(I)%20Related%20Party%20Transactions%20Related%20to%20Daily%20Operations) The company has disclosed its 2025 annual routine related party transactions in a temporary announcement, with no subsequent progress or changes in implementation - The company has disclosed its **2025** annual routine related party transactions in a temporary announcement (Announcement No.: **2024-058**), with no subsequent progress or changes in implementation[50](index=50&type=chunk) [(V) Financial Business Between the Company and Related Financial Companies, and Between the Company's Controlled Financial Companies and Related Parties](index=20&type=section&id=(V)%20Financial%20Business%20Between%20the%20Company%20and%20Related%20Financial%20Companies,%20and%20Between%20the%20Company's%20Controlled%20Financial%20Companies%20and%20Related%20Parties) The company has deposit and credit line businesses with Aerospace Science and Technology Finance Co., Ltd. At the end of the reporting period, the company's deposit balance with the financial company was **354.15 million Yuan**, with total deposits of **10.36 billion Yuan** and withdrawals of **10.87 billion Yuan** for the period; additionally, the company obtained a **150 million Yuan** comprehensive credit facility Deposit Business Information (Unit: 10,000 Yuan) | Related Party | Related Party Relationship | Daily Max Deposit Limit | Deposit Interest Rate Range | Beginning Balance | Total Deposits This Period | Total Withdrawals This Period | Ending Balance | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Aerospace Science and Technology Finance Co., Ltd. | Related financial company | Daily average transaction amount not exceeding 5,000 | 0.4%-1.37% | 86,096.17 | 1,036,320.09 | 1,087,001.35 | 35,414.91 | Credit Facility Information (Unit: 10,000 Yuan) | Related Party | Related Party Relationship | Business Type | Total Amount | Actual Amount | | :--- | :--- | :--- | :--- | :--- | | Aerospace Science and Technology Finance Co., Ltd. | Related financial company | Comprehensive credit facility (loan/acceptance) | 15,000 | 0 | [XI. Significant Contracts and Their Fulfillment](index=21&type=section&id=XI.%20Significant%20Contracts%20and%20Their%20Fulfillment) During the reporting period, the company's total external guarantees amounted to **25 million Yuan**, all for subsidiaries, representing **0.88%** of the company's net assets; the company provided joint and several liability guarantees for its subsidiaries Shantou Lucky Film Co., Ltd. and Lucky Medical Technology Co., Ltd [(II) Significant Guarantees Performed and Not Yet Completed During the Reporting Period](index=22&type=section&id=(II)%20Significant%20Guarantees%20Performed%20and%20Not%20Yet%20Completed%20During%20the%20Reporting%20Period) During the reporting period, the company had no external guarantees (excluding guarantees for subsidiaries); the amount and balance of guarantees for subsidiaries were both **25 million Yuan**, accounting for **0.88%** of the company's net assets; the company provided joint and several liability guarantees for its subsidiaries Shantou Lucky Film Co., Ltd. and Lucky Medical Technology Co., Ltd. within their respective credit limits Company Total Guarantee Amount (Unit: 10,000 Yuan) | Indicator | Amount | | :--- | :--- | | Total guarantees incurred during the reporting period (excluding guarantees for subsidiaries) | 0 | | Total guarantee balance at the end of the reporting period (A) (excluding guarantees for subsidiaries) | 0 | | Total guarantees incurred for subsidiaries during the reporting period | 2,500 | | Total guarantee balance for subsidiaries at the end of the reporting period (B) | 2,500 | | Total Guarantees (A+B) | 2,500 | | Proportion of total guarantees to company's net assets (%) | 0.88 | - The company provides joint and several liability guarantees for debts arising from specific business contracts signed by its subsidiary Shantou Lucky Film Co., Ltd. within the credit limits of ICBC Shantou Branch and Bank of Communications Shantou Branch, and for its subsidiary Lucky Medical Technology Co., Ltd. within the credit limit of Bank of China Baoding Branch[58](index=58&type=chunk) [XII. Explanation of Progress in Use of Raised Funds](index=23&type=section&id=XII.%20Explanation%20of%20Progress%20in%20Use%20of%20Raised%20Funds) The company's overall use of raised funds is good, with a cumulative investment of **862.27 million Yuan**, reaching an investment progress of **92.07%**; raised fund projects such as high-performance lithium-ion battery PE separator industrialization, phase one of lithium battery separator coating production line, aluminum-plastic film composite film industrialization, and phase four expansion of solar backsheet projects are completed or near completion; during the reporting period, the company's subsidiary Lucky Optoelectronics used **150 million Yuan** of idle raised funds to temporarily supplement working capital, which was fully repaid by July 15, 2025; the company also managed idle raised funds through cash management [(I) Overall Use of Raised Funds](index=23&type=section&id=(I)%20Overall%20Use%20of%20Raised%20Funds) The company's total raised funds amounted to **950 million Yuan**, with net raised funds of **936.59 million Yuan**; as of the end of the reporting period, the cumulative investment of raised funds totaled **862.27 million Yuan**, with an investment progress of **92.07%** Overall Use of Raised Funds (Unit: 10,000 Yuan) | Indicator | Shares Issued to Specific Objects (Arrived Jan 17, 2020) | Shares Issued to Specific Objects (Arrived May 19, 2015) | Total | | :--- | :--- | :--- | :--- | | Total Raised Funds | 35,000.00 | 60,000.00 | 95,000 | | Net Raised Funds (1) | 33,658.65 | 60,000.00 | 93,658.65 | | Total Committed Investment in Prospectus (2) | 33,658.65 | 60,000.00 | 93,658.65 | | Cumulative Investment of Raised Funds at Period-End (4) | 29,447.46 | 56,779.54 | 86,227.00 | | Cumulative Investment Progress of Raised Funds at Period-End (%) (6)＝(4)/(1) | 87.49 | 94.63 | - | | Amount Invested This Year (8) | 0.00 | 5,159.19 | 5,159.19 | | Proportion of Amount Invested for Changed Purposes to Total Raised Funds (%) (9) | 0.00 | 8.60 | - | - The **2015** net raised funds were adjusted to **600 million Yuan**, with actual net raised funds after deducting issuance expenses being **590,673,513.36 Yuan**[61](index=61&type=chunk) [(II) Details of Raised Fund Investment Projects](index=24&type=section&id=(II)%20Details%20of%20Raised%20Fund%20Investment%20Projects) Several of the company's raised fund investment projects are completed or near completion, including high-performance lithium-ion battery PE separator industrialization, phase one of lithium battery separator coating production line, aluminum-plastic film composite film industrialization, and phase four expansion of solar backsheet projects, all reaching **100%** investment progress; the TAC film 3 production line project and the annual production of **50 million square meters** of multi-functional coated composite materials technical upgrade and expansion project are still under construction, while the high-performance separation membrane and components project has exceeded its planned investment Details of Raised Fund Investment Projects Usage (Unit: 10,000 Yuan) | Source of Raised Funds | Project Name | Project Nature | Committed Investment Project in Prospectus | Involves Change in Investment Direction | Planned Investment (1) | Amount Invested This Year | Cumulative Investment of Raised Funds at Period-End (2) | Cumulative Investment Progress (%) (3)＝(2)/(1) | Date Project Reached Intended Usable State | Is Project Closed | Is Investment Progress in Line with Plan | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Shares Issued to Specific Objects | High-Performance Lithium-Ion Battery PE Separator Industrialization Project | Production and Construction | Yes | No | 20649.36 | 0 | 20,649.36 | 100.00 | July 1, 2017 | Yes | Yes | | Shares Issued to Specific Objects | Phase One of Lithium Battery Separator Coating Production Line Project | Production and Construction | Yes | No | 2997.87 | 0 | 2,997.87 | 100.00 | July 1, 2017 | Yes | Yes | | Shares Issued to Specific Objects | Lithium-Ion Battery Soft Pack Aluminum-Plastic Composite Film Industrialization Project | Production and Construction | No | Yes, this is a new project | 11426.07 | 0 | 11,426.07 | 100.00 | December 26, 2022 | Yes | Yes | | Shares Issued to Specific Objects | Phase Four Expansion of Solar Backsheet Project—No. 8 Production Line | Production and Construction | Yes | No | 2,573.87 | 0 | 2,573.87 | 100.00 | October 1, 2015 | Yes | Yes | | Shares Issued to Specific Objects | Phase Four Expansion of Solar Backsheet Project—No. 14, 15 Production Lines | - | Yes | - | 110.54 | 0 | 110.54 | 100.00 | - | Yes | No (Changed to TAC Film 3 Production Line Project) | | Shares Issued to Specific Objects | TAC Film 3 Production Line Project① | Production and Construction | No | Yes, this is a new project | 12,889.46 | 2,277.77 | 13,048.47 | 101.23 | July 31, 2025 | No | Yes | | Shares Issued to Specific Objects | Annual Production of 50 Million Square Meters of Multi-Functional Coated Composite Materials Technical Upgrade and Expansion Project | Production and Construction | No | No | 8,345 | 1,502.66 | 4,594.60 | 55.06 | October 31, 2025 | No | Yes | | Shares Issued to Specific Objects | Acquisition of 100% Equity in Lucky Optoelectronics | Other | No | Yes, this is a new project | 28,253.46 | 0 | 28,253.46 | 100.00 | January 26, 2024 | Yes | Yes | | Shares Issued to Specific Objects | TAC Film 3 Production Line Project② | Production and Construction | No | Yes, this is a new project | 5,326.56 | 0 | 1,194 | 22.42 | July 31, 2025 | No | Yes | | Shares Issued to Specific Objects | High-Performance Separation Membrane and Components Project | Production and Construction | No | Yes, this is a new project | 1,086.46 | 1,378.76 | 1,378.76 | 126.90 | January 31, 2027 | No | Yes | [(IV) Other Uses of Raised Funds During the Reporting Period](index=26&type=section&id=(IV)%20Other%20Uses%20of%20Raised%20Funds%20During%20the%20Reporting%20Period) During the reporting period, the company's subsidiary Lucky Optoelectronics used **150 million Yuan** of idle raised funds to temporarily supplement working capital, which was fully repaid by July 15, 2025; additionally, the company managed idle raised funds through cash management, with an ending balance of **120 million Yuan** - The company's subsidiary Lucky Optoelectronics used **150 million Yuan** of idle raised funds to temporarily supplement working capital, which was fully repaid to the special raised funds account by **July 15, 2025**[65](index=65&type=chunk) Cash Management of Idle Raised Funds (Unit: 10,000 Yuan) | Board of Directors Review Date | Authorized Amount | Start Date | End Date | Ending Balance of Cash Management | Is Balance Exceeding Authorized Amount | | :--- | :--- | :--- | :--- | :--- | :--- | | March 14, 2025 | 12,000 | March 14, 2025 | March 13, 2026 | 12,000 | No | [Section 6 Share Changes and Shareholder Information](index=26&type=section&id=Section%206%20Share%20Changes%20and%20Shareholder%20Information) [I. Changes in Share Capital](index=26&type=section&id=I.%20Changes%20in%20Share%20Capital) During the reporting period, there were no changes in the company's total share capital or share structure - During the reporting period, there were no changes in the company's total share capital or share structure[69](index=69&type=chunk) [II. Shareholder Information](index=27&type=section&id=II.%20Shareholder%20Information) As of the end of the reporting period, the company had **26,280** common shareholders; among the top ten shareholders, China Lucky Group Corporation is the controlling shareholder with a **45.68%** stake, while the remaining are individual shareholders with relatively low ownership percentages - As of the end of the reporting period, the company had **26,280** common shareholders[70](index=70&type=chunk) Top Ten Shareholders' Holdings (Excluding Shares Lent via Securities Relending) | Shareholder Name | Ending Shareholding (Shares) | Proportion (%) | Shareholder Type | | :--- | :--- | :--- | :--- | | China Lucky Group Corporation | 252,776,443 | 45.68 | State-owned Legal Entity | | Wang Chengping | 3,000,000 | 0.54 | Unknown | | Gao Xiankang | 2,515,201 | 0.45 | Unknown | | Qin Ziyu | 2,209,000 | 0.40 | Unknown | | Lin Youming | 2,177,900 | 0.39 | Unknown | | Hu Guohao | 1,900,000 | 0.34 | Unknown | | Jin Feng | 1,565,600 | 0.28 | Unknown | | Ruan Baoqin | 1,550,000 | 0.28 | Unknown | | Zhu Yongcun | 1,399,900 | 0.25 | Unknown | | Shen Miaoqing | 1,330,600 | 0.24 | Unknown | - China Lucky Group Corporation is the company's controlling shareholder, holding **252,776,443** unrestricted tradable shares[71](index=71&type=chunk) [Section 7 Bond-Related Information](index=29&type=section&id=Section%207%20Bond-Related%20Information) [I. Corporate Bonds (Including Enterprise Bonds) and Non-Financial Enterprise Debt Financing Instruments](index=29&type=section&id=I.%20Corporate%20Bonds%20(Including%20Enterprise%20Bonds)%20and%20Non-Financial%20Enterprise%20Debt%20Financing%20Instruments) During the reporting period, the company had no corporate bonds (including enterprise bonds) or non-financial enterprise debt financing instruments [II. Convertible Corporate Bonds](index=29&type=section&id=II.%20Convertible%20Corporate%20Bonds) During the reporting period, the company had no convertible corporate bonds [Section 8 Financial Report](index=30&type=section&id=Section%208%20Financial%20Report) [II. Financial Statements](index=30&type=section&id=II.%20Financial%20Statements) This section provides the company's 2025 semi-annual consolidated and parent company balance sheets, income statements, cash flow statements, and statements of changes in owners' equity, comprehensively reflecting the company's financial position at the end of the reporting period and its operating results, cash flows, and changes in owners' equity during the reporting period - The consolidated balance sheet shows total assets of **3,232,103,349.88 Yuan** at period-end, with total owners' equity attributable to the parent company of **2,418,336,123.60 Yuan**[79](index=79&type=chunk) - The consolidated income statement shows total operating revenue of **643,586,281.25 Yuan** for the current period, and net profit attributable to parent company shareholders of **-52,939,432.17 Yuan**[84](index=84&type=chunk)[85](index=85&type=chunk) - The consolidated cash flow statement shows net cash flow from operating activities of **-102,762,749.76 Yuan** and net cash flow from investing activities of **-359,714,560.72 Yuan**[90](index=90&type=chunk)[91](index=91&type=chunk) [III. Company Basic Information](index=45&type=section&id=III.%20Company%20Basic%20Information) Lucky Film Company Limited was registered on January 16, 1998, and listed on the Shanghai Stock Exchange on January 22, with a unified social credit code of 911300007007101420, operating in the chemical raw materials and chemical products manufacturing industry; through multiple non-public offerings and asset acquisitions, the company has cumulatively issued **553,307,099** shares, with a registered capital of **553,307,099 Yuan**; its main business focuses on image information materials and new energy materials, with key products including solar backsheets, color photographic paper, lithium-ion battery separators, medical films, and TAC films; the company's parent company is China Lucky Group Corporation, and its ultimate controlling party is China Aerospace Science and Technology Corporation - Lucky Film Company Limited was registered on **January 16, 1998**, and listed on the Shanghai Stock Exchange on **January 22**, with stock code **600135**[103](index=103&type=chunk) - The company has cumulatively issued **553,307,099** shares, with a registered capital of **553,307,099 Yuan**[105](index=105&type=chunk) - The company's main business focuses on image information materials and new energy materials, with key products including solar backsheets, color photographic paper, inkjet printing paper, processing chemicals for information imaging materials, lithium-ion battery separators, medical films, and TAC films[105](index=105&type=chunk) - The company's parent company is China Lucky Group Corporation, and its ultimate controlling party is China Aerospace Science and Technology Corporation[105](index=105&type=chunk) [IV. Basis for Preparation of Financial Statements](index=45&type=section&id=IV.%20Basis%20for%20Preparation%20of%20Financial%20Statements) The company's financial statements are prepared on a going concern basis, adhering to the Accounting Standards for Business Enterprises issued by the Ministry of Finance and relevant regulations of the China Securities Regulatory Commission, accurately and completely reflecting the company's financial position, operating results, changes in shareholders' equity, and cash flows - The company's financial statements are prepared on a going concern basis[106](index=106&type=chunk)[107](index=107&type=chunk) - The financial statements are prepared in accordance with the Accounting Standards for Business Enterprises issued by the Ministry of Finance and the China Securities Regulatory Commission's 'No. 15 Rules for the Preparation of Information Disclosure by Companies Issuing Securities to the Public - General Provisions on Financial Reports'[106](index=106&type=chunk) [V. Significant Accounting Policies and Estimates](index=46&type=section&id=V.%20Significant%20Accounting%20Policies%20and%20Estimates) This section elaborates on the significant accounting policies and estimates followed by the company in preparing its financial statements, covering financial instruments, inventories, fixed assets, intangible assets, revenue recognition, employee compensation, deferred income tax, and other areas, with specific explanations for fixed asset depreciation, intangible asset amortization, R&D expense capitalization conditions, and revenue recognition policies determined based on the company's operational characteristics - The company determines fixed asset depreciation, intangible asset amortization, R&D expense capitalization conditions, and revenue recognition policies based on its specific production and operational characteristics[108](index=108&type=chunk) - The company classifies financial assets as those measured at amortized cost, those measured at fair value with changes recognized in other comprehensive income, and those measured at fair value with changes recognized in current profit or loss[125](index=125&type=chunk) - The company accrues loss provisions for financial instruments based on expected credit losses and measures them in different stages according to changes in credit risk[137](index=137&type=chunk)[138](index=138&type=chunk) - The company recognizes revenue when it fulfills its performance obligations in a contract, i.e., when the customer obtains control of the relevant goods or services[190](index=190&type=chunk) [VI. Taxation](index=69&type=section&id=VI.%20Taxation) This section discloses the company's main tax categories and rates, including Value-Added Tax, Urban Maintenance and Construction Tax, Education Surcharge, and Local Education Surcharge; the company and several of its subsidiaries enjoy high-tech enterprise tax incentives, applying a **15%** corporate income tax rate; some subsidiaries, as small low-profit enterprises, benefit from a preferential policy where the portion of annual taxable income not exceeding **1 million Yuan** is reduced by **25%** and taxed at a **20%** corporate income tax rate Major Tax Categories and Rates | Tax Category | Tax Basis | Tax Rate | | :--- | :--- | :--- | | Value-Added Tax | Taxable value-added amount | 13%, 6%, 5% | | Urban Maintenance and Construction Tax | Actual amount of turnover tax paid | 7%, 5% | | Education Surcharge | Actual amount of turnover tax paid | 3% | | Local Education Surcharge | Actual amount of turnover tax paid | 2% | - Lucky Film Company Limited, Baoding Lucky Imaging Materials Technology Co., Ltd., Shantou Lucky Film Co., Ltd., Lucky Medical Technology Co., Ltd., and Lucky Optoelectronics Materials Co., Ltd. are all recognized as high-tech enterprises, applying a **15%** corporate income tax rate[219](index=219&type=chunk)[220](index=220&type=chunk) - Baoding Lucky Import & Export Trading Co., Ltd. and Beijing Lucky Film Sales Co., Ltd. enjoy preferential corporate income tax policies for small low-profit enterprises, where the portion of annual taxable income not exceeding **1 million Yuan** is reduced by **25%** and taxed at a **20%** corporate income tax rate[220](index=220&type=chunk) [VII. Notes to Consolidated Financial Statement Items](index=70&type=section&id=VII.%20Notes%20to%20Consolidated%20Financial%20Statement%20Items) This section provides detailed notes on significant items in the consolidated financial statements, including monetary funds, trading financial assets, notes receivable, accounts receivable, inventories, fixed assets, construction in progress, intangible assets, deferred tax assets/liabilities, short-term borrowings, accounts payable, contract liabilities, employee compensation payable, taxes payable, other payables, lease liabilities, deferred income, share capital, capital reserves, other comprehensive income, special reserves, surplus reserves, undistributed profits, operating revenue and costs, taxes and surcharges, selling expenses, administrative expenses, R&D expenses, financial expenses, other income, investment income, fair value change gains, credit impairment losses, asset impairment losses, asset disposal gains, non-operating income and expenses, income tax expenses, and cash flow statement items, providing ending balances, beginning balances, current period changes, and related explanations for each item - The ending balance of monetary funds was **813,807,951.11 Yuan**, of which **392,105,701.01 Yuan** were restricted monetary funds[222](index=222&type=chunk)[223](index=223&type=chunk) - The ending balance of trading financial assets was **421,629,274.55 Yuan**, primarily consisting of structured deposits[228](index=228&type=chunk) - The ending book value of accounts receivable was **215,169,078.72 Yuan**, with a bad debt provision of **54,944,438.23 Yuan**[238](index=238&type=chunk) - The ending book value of inventories was **306,828,583.16 Yuan**, with inventory impairment provisions and contract performance cost impairment provisions totaling **13,927,162.41 Yuan**[274](index=274&type=chunk)[276](index=276&type=chunk) - The ending book value of fixed assets was **528,129,615.61 Yuan**, with accumulated depreciation of **1,403,547,779.97 Yuan**[290](index=290&type=chunk) - Operating revenue for the current period was **643,586,281.25 Yuan**, and operating cost was **557,181,902.10 Yuan**[353](index=353&type=chunk) - Net cash flow from operating activities was **-102,762,749.76 Yuan**[383](index=383&type=chunk) [VIII. Research and Development Expenses](index=122&type=section&id=VIII.%20Research%20and%20Development%20Expenses) During the reporting period, the company's total R&D expenditure was **50,289,155.09 Yuan**, entirely expensed, primarily comprising employee compensation, testing fees, and material costs; R&D expenditure slightly decreased compared to the same period last year R&D Expenses by Nature of Expense (Unit: Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Employee Compensation | 17,169,813.30 | 16,911,293.56 | | Testing Fees | 13,193,271.70 | 12,996,555.85 | | Materials | 10,285,662.36 | 11,088,847.56 | | Energy Costs | 2,009,905.77 | 1,879,066.10 | | Fixed Asset Depreciation | 1,815,517.50 | 1,515,173.51 | | Consulting Fees | 1,450,579.44 | 693,831.75 | | Intangible Asset Amortization | 962,859.30 | 962,859.30 | | Labor Costs | 712,179.33 | 758,843.34 | | Travel Expenses | 421,500.36 | 460,463.49 | | Lease Fees | 307,285.69 | 269,794.26 | | Other | 1,960,580.34 | 3,068,414.73 | | **Total** | **50,289,155.09** | **50,605,143.45** | | Of which: Expensed R&D Expenditure | 50,289,155.09 | 50,605,143.45 | | Capitalized R&D Expenditure | - | - | [IX. Changes in Consolidation Scope](index=123&type=section&id=IX.%20Changes%20in%20Consolidation%20Scope) During the reporting period, the company had no changes in its consolidation scope due to business combinations not under common control, business combinations under common control, reverse acquisitions, disposal of subsidiaries, or other reasons [X. Interests in Other Entities](index=124&type=section&id=X.%20Interests%20in%20Other%20Entities) This section discloses the company's equity interests in its subsidiaries, including the registered place, business nature, registered capital, and shareholding ratio of major subsidiaries such as Shantou Lucky Film Co., Ltd., Baoding Lucky Imaging Materials Technology Co., Ltd., Beijing Lucky Film Sales Co., Ltd., Baoding Lucky Import & Export Trading Co., Ltd., Lucky Medical Technology Co., Ltd., and Lucky Optoelectronics Materials Co., Ltd.; among these, Baoding Lucky Imaging Materials Technology Co., Ltd. and Lucky Optoelectronics Materials Co., Ltd. are significant non-wholly-owned subsidiaries, with minority shareholder stakes of **54.72%** and **43.56%** respectively Composition of Enterprise Group (Unit: 10,000 Yuan) | Subsidiary Name | Registered Place | Registered Capital | Main Operating Place | Business Nature | Direct Shareholding (%) | Indirect Shareholding (%) | Acquisition Method | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Shantou Lucky Film Co., Ltd. | Shantou City, Guangdong Province | 8,000.00 | Shantou City, Guangdong Province | Production and Sales | 100.00 | - | Investment Establishment | | Baoding Lucky Imaging Materials Technology Co., Ltd. | Baoding City, Hebei Province | 3,140.00 | Baoding City, Hebei Province | Production and Sales | 45.28 | - | Investment Establishment | | Beijing Lucky Film Sales Co., Ltd. | Baoding City, Hebei Province | 950.00 | Baoding City, Hebei Province | Sales | 100.00 | - | Investment Establishment | | Baoding Lucky Import & Export Trading Co., Ltd. | Baoding City, Hebei Province | 100.00 | Baoding City, Hebei Province | Sales | 100.00 | - | Business Combination Under Common Control | | Lucky Medical Technology Co., Ltd. | Baoding City, Hebei Province | 12,988.05 | Baoding City, Hebei Province | Production and Sales | 100.00 | - | Business Combination Under Common Control | | Lucky Optoelectronics Materials Co., Ltd. | Suqian City, Jiangsu Province | 17,718.09 | Suqian City, Jiangsu Province | Production and Sales | 56.44 | - | Business Combination Under Common Control | Significant Non-Wholly-Owned Subsidiaries (Unit: Yuan) | Subsidiary Name | Minority Shareholding (%) | P/L Attributable to Minority Shareholders This Period | Dividends Declared to Minority Shareholders This Period | Ending Balance of Minority Interests | | :--- | :--- | :--- | :--- | :--- | | Baoding Lucky Imaging Materials Technology Co., Ltd. | 54.72 | 371,878.40 | - | 19,942,243.16 | | Lucky Optoelectronics Materials Co., Ltd. | 43.56 | 2,632,264.76 | - | 414,221,634.24 | [XI. Government Grants](index=127&type=section&id=XI.%20Government%20Grants) During the reporting period, the company's government grant-related liability items primarily consisted of deferred income, with an ending balance of **43,717,869.06 Yuan**, a decrease of **3,717,081.22 Yuan** for the period, mainly due to asset-related government grants recognized in other income; total government grants recognized in current profit or loss for the period amounted to **4,010,070.41 Yuan**, of which **3,617,081.22 Yuan** were asset-related and **392,989.19 Yuan** were income-related Liability Items Involving Government Grants (Unit: Yuan) | Financial Statement Item | Beginning Balance | New Grants This Period | Amount Recognized in Non-Operating Income This Period | Transferred to Other Income This Period | Other Changes This Period | Ending Balance | Asset/Income Related | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Deferred Income | 47,434,950.28 | - | - | 3,717,081.22 | - | 43,717,869.06 | Asset-related | | **Total** | **47,434,950.28** | **-** | **-** | **3,717,081.22** | **-** | **43,717,869.06** | / | Government Grants Recognized in Current Profit or Loss (Unit: Yuan) | Type | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Asset-related | 3,617,081.22 | 3,717,081.23 | | Income-related | 392,989.19 | 773,611.41 | | **Total** | **4,010,070.41** | **4,490,692.64** | [XII. Risks Related to Financial Instruments](index=128&type=section&id=XII.%20Risks%20Related%20to%20Financial%20Instruments) The company primarily faces credit risk, liquidity risk, and market risk (including interest rate risk and exchange rate risk); the company manages and monitors these risk exposures to ensure they remain within controllable limits; credit risk is controlled mainly by assessing customer creditworthiness, regular monitoring, and purchasing credit guarantee insurance; liquidity risk is managed by maintaining sufficient cash and cash equivalents and bank credit lines; regarding market risk, the company closely monitors interest rate and exchange rate fluctuations but currently does not employ hedging policies - The company's main financial instruments include monetary funds, notes receivable, accounts receivable, accounts receivable financing, other receivables, trading financial assets, other equity instrument investments, notes payable, accounts payable, other payables, short-term borrowings, lease liabilities, and long-term payables[405](index=405&

证券代码：600135 证券简称：乐凯胶片 公告编号：2025-042 乐凯胶片股份有限公司 2025 年第二季度主要经营数据 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 乐凯胶片股份有限公司（以下简称"本公司"）根据《上海证券交易所上市公 司自律监管指引第 3 号——行业信息披露》第十三号附件的相关规定，将 2025 年第二季度主要经营数据公告如下： 一、2025 年第二季度主要产品经营情况 | 产品名称 | 单位 | 产量 | 销量 | 销售收入 （人民币万元） | | --- | --- | --- | --- | --- | | 银盐产品 | | | | | | 彩色相纸 | 万平米 | 1,356.02 | 1,330.28 | 14,784.89 | | 光伏产品 | | | | | | 太阳能电池背板 | 万平米 | 82.70 | 115.20 | 639.40 | | 医疗产品 | | | | | | 医用干式胶片 | 万平米 | 388.36 | 404.94 | 5,528.17 | | 光电产品 | | | | | | ...

证券代码:600135 证券简称:乐凯胶片 公告编号：2025-044 本公司及董事会全体成员保证公告内容的真实、准确和完整，对公告的虚 假记载、误导性陈述或者重大遗漏负连带责任。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集 资金管理和使用的监管要求》及《上海证券交易所上市公司自律监管指引第 1 号——规范运作》的有关规定，现将乐凯胶片股份有限公司（以下简称"本公司" 或"公司"）2025 年半年度募集资金存放与实际使用情况专项说明如下： 一、募集资金基本情况 乐凯胶片股份有限公司 2025 年半年度募集资金存放与实际使用情况专项报告 （一） 2014年非公开发行募集资金 1.实际募集资金金额、资金到位情况 2015 年 4 月，本公司经中国证券监督管理委员会《关于核准乐凯胶片股份 有限公司非公开发行股票的批复》（证监许可〔2015〕698 号）批准，非公开发 行人民币普通股 30,991,735 股，每股发行价 19.36 元，募集资金总额为 599,999,989.60 元，扣除各项发行费用 9,326,476.24 元后的实际募集资金净额为 590,673,513.36 元。 ...

乐凯胶片股份有限公司 关于对航天科技财务有限责任公司的风险评估报告 根据上交所《上海证券交易所上市公司信息披露指引第 5 号— 交易与关联交易》的要求，乐凯胶片股份有限公司（以下简称"本公 司"）通过查验航天科技财务有限责任公司（以下简称"航天财务公 司"）的《营业执照》与《金融许可证》等资料，审阅了包括资产负 债表、利润表、现金流量表等在内的航天财务公司定期财务报告，审 阅了航天财务公司 2025 年上半年内控与风险情况报告，对航天财务 公司的经营资质、内部控制设计和全面风险管理进行了评估，具体情 况报告如下： 注册地址：北京市西城区平安里西大街 31 号-01 至 03 层，07 至 09 层 法定代表人：史伟国 金融许可证机构编码：L0015H211000001 统一社会信用代码：91110000710928911P 股东情况：航天财务公司注册资本金 65 亿元，其中：中国航 天科技集团有限公司出资占比 30.20%；中国运载火箭技术研究院出 资占比 14.56%；中国空间技术研究院出资占比 10.92%；上海航天技 术研究院出资占比 10.01%；航天动力技术研究院出资占比 9.10%；西 安航天科技 ...